Camex Ltd Stock Falls to 52-Week Low of Rs.28.1 Amidst Weak Financial Metrics

Stock Price Movement and Market Context

The stock’s decline to Rs.28.1 represents a sharp contrast to its 52-week high of Rs.46.29, underscoring a 39.3% drop from its peak price. While Camex Ltd outperformed its sector by 3.06% today and has recorded gains of 2.81% over the last two consecutive sessions, it remains firmly below all key moving averages, including the 5-day, 20-day, 50-day, 100-day, and 200-day averages. This technical positioning signals sustained downward pressure on the stock.

In comparison, the broader market index, Sensex, has experienced a decline of 0.88% today, closing at 82,559.98 points after falling 492.56 points from its opening. The Sensex remains 4.36% shy of its 52-week high of 86,159.02, trading below its 50-day moving average, although the 50DMA itself is positioned above the 200DMA, indicating some underlying market resilience.

Financial Performance and Fundamental Metrics

Camex Ltd’s financial performance over the past year has been subdued, with the stock delivering a negative return of 20.58%, significantly underperforming the Sensex’s positive 10.89% return over the same period. The company’s long-term growth has been modest, with net sales increasing at an annualised rate of just 3.00% over the last five years.

Return on Capital Employed (ROCE), a key indicator of capital efficiency, has remained weak, averaging 5.09% over the long term and declining to a low of 4.29% in the most recent half-year period. This figure is below industry norms and highlights limited profitability from the company’s capital investments.

Additionally, the Debtors Turnover Ratio, which measures the efficiency of receivables collection, stood at a low 5.91 times in the half-year, suggesting slower cash conversion cycles. The company’s Return on Equity (ROE) is also modest at 3.7%, reflecting limited returns generated on shareholders’ equity.

Valuation and Shareholding Structure

The stock currently trades at a Price to Book Value ratio of 0.7, indicating a fair valuation relative to its book value. However, this valuation is at a premium compared to the average historical valuations of its peers in the commodity chemicals sector. Despite this, the company’s profitability has contracted sharply, with profits declining by 52.7% over the past year.

Majority ownership of Camex Ltd rests with non-institutional shareholders, which may influence liquidity and trading dynamics. The company’s market capitalisation grade is rated 4, reflecting its mid-tier market cap status within the sector.

Performance Trends and Ratings

Over the last three years, Camex Ltd has consistently underperformed the BSE500 index, with negative returns recorded over one year, three years, and the most recent three-month period. This sustained underperformance has contributed to a downgrade in its Mojo Grade from Sell to Strong Sell as of 31 July 2023, with a current Mojo Score of 20.0, signalling significant caution.

The company’s flat financial results reported in December 2025 further underscore the challenges faced in improving profitability and growth momentum. The combination of weak long-term fundamental strength and subdued growth prospects has weighed heavily on investor sentiment and stock performance.

Summary of Key Metrics

To summarise, Camex Ltd’s stock has reached a new 52-week low of Rs.28.1, reflecting a decline of over 39% from its 52-week high of Rs.46.29. The stock’s performance over the past year has been negative at -20.58%, contrasting with the Sensex’s positive 10.89% return. The company’s financial indicators, including ROCE at 5.09%, ROE at 3.7%, and a significant 52.7% drop in profits, highlight ongoing pressures on growth and profitability.

Despite a recent two-day gain of 2.81%, Camex Ltd remains below all major moving averages, signalling continued caution among market participants. The downgrade to a Strong Sell rating and a Mojo Score of 20.0 further reflect the stock’s current standing within the commodity chemicals sector.